- Home
- FOLD vs GRND Comparison
FOLD vs GRND Comparison
Compare FOLD & GRND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- GRND
- Stock Information
- Founded
- FOLD 2002
- GRND 2009
- Country
- FOLD United States
- GRND United States
- Employees
- FOLD N/A
- GRND N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- GRND Computer Software: Prepackaged Software
- Sector
- FOLD Health Care
- GRND Technology
- Exchange
- FOLD Nasdaq
- GRND Nasdaq
- Market Cap
- FOLD 2.5B
- GRND 2.5B
- IPO Year
- FOLD 2007
- GRND N/A
- Fundamental
- Price
- FOLD $9.41
- GRND $14.72
- Analyst Decision
- FOLD Buy
- GRND Strong Buy
- Analyst Count
- FOLD 7
- GRND 5
- Target Price
- FOLD $30.29
- GRND $22.40
- AVG Volume (30 Days)
- FOLD 5.0M
- GRND 2.9M
- Earning Date
- FOLD 11-04-2025
- GRND 11-06-2025
- Dividend Yield
- FOLD N/A
- GRND N/A
- EPS Growth
- FOLD N/A
- GRND N/A
- EPS
- FOLD N/A
- GRND N/A
- Revenue
- FOLD $598,704,000.00
- GRND $411,545,000.00
- Revenue This Year
- FOLD $21.12
- GRND $28.55
- Revenue Next Year
- FOLD $21.23
- GRND $22.20
- P/E Ratio
- FOLD N/A
- GRND N/A
- Revenue Growth
- FOLD 21.28
- GRND 28.97
- 52 Week Low
- FOLD $5.51
- GRND $11.73
- 52 Week High
- FOLD $10.83
- GRND $25.13
- Technical
- Relative Strength Index (RSI)
- FOLD 67.64
- GRND 54.54
- Support Level
- FOLD $8.69
- GRND $13.00
- Resistance Level
- FOLD $9.64
- GRND $15.59
- Average True Range (ATR)
- FOLD 0.38
- GRND 0.78
- MACD
- FOLD 0.03
- GRND 0.22
- Stochastic Oscillator
- FOLD 82.68
- GRND 52.81
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.